Cotterchio M, Kreiger N, Darlington G, Steingart A
Division of Preventive Oncology, Cancer Care Ontario, Toronto, Canada.
Ann Epidemiol. 1999 Jul;9(5):283-9. doi: 10.1016/s1047-2797(98)00072-6.
Self-reported medication histories obtained in pharmacoepidemiologic case-control studies are subject to non-differential misclassification and to recall bias. The accuracy of self-reported antidepressant medication use has never been evaluated, but it is important in light of the hypothesis that antidepressant medications may be associated with cancer risk.
Within a case-control study of several cancer sites, we compared self-reported antidepressant medication use with antidepressant use recorded in physicians' records. All female cases (n = 147) and controls (n = 119) who reported antidepressant medication use, and a 10% random sample (n = 114) of those who reported no antidepressant use, were asked to provide consent to contact, and the name(s) of their physician(s). These physicians completed a data abstraction form including information on antidepressant prescriptions recorded in patients' medical records.
Substantial agreement was found between subject- and physician-reported antidepressant medication use (kappa = 0.60 [95% confidence interval (CI), 0.47-0.74]; agreement = 80%), and use of specific antidepressant medications (agreement ranged from 82 to 100%), while moderate agreement was observed for duration of use (weighted kappa = 0.56 (95% CI, 0.32-0.79)), and date of first use [weighted kappa = 0.48 (95% CI, 0.23-0.72)]. The level of agreement did not differ markedly between cases and controls, except for duration of use, where agreement was somewhat greater for cases.
The similar level of agreement among cases and controls suggests that differential misclassification (e.g., recall bias) is unlikely in the reporting of most aspects of antidepressant medication use by women. Furthermore, the overall accurate self-reporting of antidepressant use suggests that there should be minimal non-differential antidepressant exposure misclassification.
在药物流行病学病例对照研究中获取的自我报告用药史存在非差异性错误分类和回忆偏倚。自我报告的抗抑郁药物使用准确性从未得到评估,但鉴于抗抑郁药物可能与癌症风险相关的假设,这一点很重要。
在一项针对多个癌症部位的病例对照研究中,我们将自我报告的抗抑郁药物使用情况与医生记录中记载的抗抑郁药物使用情况进行了比较。所有报告使用抗抑郁药物的女性病例(n = 147)和对照(n = 119),以及10%随机抽取的报告未使用抗抑郁药物的样本(n = 114),被要求提供同意联系的许可及其医生的姓名。这些医生填写了一份数据提取表,其中包括患者病历中记录的抗抑郁药物处方信息。
在受试者报告和医生报告的抗抑郁药物使用情况之间发现了高度一致性(kappa = 0.60 [95%置信区间(CI),0.47 - 0.74];一致性 = 80%),以及特定抗抑郁药物的使用情况(一致性范围为82%至100%),而在使用持续时间方面观察到中等一致性(加权kappa = 0.56 [95% CI,0.32 - 0.79]),以及首次使用日期[加权kappa = 0.48 [95% CI,0.23 - 0.72]]。病例组和对照组之间的一致性水平没有明显差异,但在使用持续时间方面除外,病例组的一致性略高。
病例组和对照组之间相似的一致性水平表明,女性在报告抗抑郁药物使用的大多数方面不太可能存在差异性错误分类(例如,回忆偏倚)。此外,抗抑郁药物使用的总体准确自我报告表明,非差异性抗抑郁药物暴露错误分类应最小化。